TY - BOOK ID - 5512687 TI - Bioindustry ethics PY - 2005 SN - 9780123693709 0123693705 9786611005337 1281005339 0080492517 9780080492513 9781281005335 PB - Amsterdam ; Boston : Elsevier Academic Press, DB - UniCat KW - Bioethics. KW - Biotechnology KW - Drug Industry KW - Ethics, Business. KW - Biotechnology industries KW - Pharmaceutical industry KW - Business ethics KW - Bio-industries KW - Industrie pharmaceutique KW - Morale des affaires KW - ethics. KW - Moral and ethical aspects KW - Aspect moral KW - Biotechnology industries. KW - Business ethics. KW - Moral and ethical aspects. KW - Pharmaceutical industry. KW - Industry KW - Ethics KW - Technology KW - Biological Science Disciplines KW - Technology, Industry, and Agriculture KW - Humanities KW - Health Care Quality, Access, and Evaluation KW - Natural Science Disciplines KW - Technology, Industry, Agriculture KW - Disciplines and Occupations KW - Health Care KW - Bioethics KW - Ethics, Business KW - Business & Economics KW - Industries KW - Business KW - Businesspeople KW - Commercial ethics KW - Corporate ethics KW - Corporation ethics KW - Drug industry KW - Drug trade KW - Professional ethics KW - Wealth KW - Medicine industry KW - Medicines industry KW - Prescription medicine industry KW - Chemical industry KW - High technology industries KW - Biomedical industries UR - https://www.unicat.be/uniCat?func=search&query=sysid:5512687 AB - This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represen ER -